Veon Ltd (NASDAQ:VEON) shares traded -0.26% down during most recent session to reach at the closing price of $3.77. The stock exchanged hands 10.91 Million shares versus average trading capacity of 3.19 Million shares, yielding a market cap of $6.75 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $5.32 within the next 52-weeks. The mean target projections are based on 13 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Veon Ltd (NASDAQ:VEON) high price target of $6.5 and with a conservative view have low price target of $4.
On the other hand the company has Relative Strength Index (RSI 14) of 40.46 along with Average True Range (ATR 14) of 0.1, Consequently Veon Ltd (NASDAQ:VEON)’s weekly and monthly volatility is 3.33%, 2.42% respectively. The company’s beta value is at 2.28.
In terms of Buy, Sell or Hold recommendations, Veon Ltd (NASDAQ:VEON) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
Currently Veon Ltd (NASDAQ:VEON)’s shares owned by insiders are 39.6%, whereas shares owned by institutional owners are 10.8%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 3.56%.
Veon Ltd (NASDAQ:VEON) 52-week high price stands at $4.51 and low price stands at $3.12, its price distance from 52-week high is -16.41% while its distance from 52-week low price is 20.83%. The stock hit its 52-week high on 08/12/16, and 52-week low on 10/24/16.
Veon Ltd (NASDAQ:VEON)’s trailing twelve month revenues are $9.14 Billion, whereas its price to sales ratio for the same period is 0.74. Its book value per share for the most recent quarter is $3.27 while its price to book ratio for the same period is 1.15, as for as the company’s cash per share for the most recent quarter is $1.36, however its price to cash per share ratio for the same period is 2.78. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.